Skip directly to site content Skip directly to search


Español  Other Languages


Centers for Disease Control and Prevention. CDC twenty four seven. Saving Lives, Protecting People
 Search
		×
			NIOSH
			NIOSH
				All CDC
				Submit
			For a full list of topics:A-Z Index
			Advanced Search
		Advanced Search


The National Personal Protective Technology Laboratory (NPPTL)








NIOSH Conformity Assessment Letter to Manufacturers						Print
																Related Pages
										**Subject:** NIOSH fraud and fraudulent statements policy and information about the NIOSH Respirator Approval Program certification marks.
This notice supersedes NIOSH CA 2022-1041-R1.NIOSH CA 2023-1056
April 2023
The NIOSH Fraud and Fraudulent Statements Policy, published as a letter to manufacturers in July 2022 (NIOSH CA 2022-1041-R1), has been updated because the HHS COVID-19 public health emergency is no longer being renewed effective May 11, 2023. This notice provides updated information for NIOSH approval holders, applicants, and other interested parties about several NIOSH Respirator Approval Program certification marks that have been registered with the U.S. Patent and Trademark Office (USPTO).
NIOSH RESPIRATOR APPROVAL PROGRAM CERTIFICATION MARKS
NIOSH, on behalf of the Department of Health and Human Services (HHS), registered several certification marks with the USPTO that are specific to NIOSH Approved® respirators to help combat the sale of respirators that are counterfeit or are misrepresented as being approved by NIOSH. These registered certification marks currently include the NIOSH stylized logos with and without full text, NIOSH Approved®, and certification marks, such as N95® and P100®, that correspond to the approved respiratory protection levels for powered and non-powered air-purifying respirators (APRs). The registered certification marks can be found on the NIOSH **Post-market Evaluations Conducted by NIOSH** webpage under the section *Protecting End Users from Wearing Respirators Being Misrepresented as NIOSH Approved® Respirators*.
HHS is the owner of these certification marks and NIOSH, as the certifying federal entity for the Respirator Approval Program, is the custodian of these marks. This means that NIOSH administers and controls who can use these marks. Accordingly, the certification marks may only be used by approval holders in reference to respirators that NIOSH has approved under Title 42, Part 84, of the Code of Federal Regulations (42 C.F.R. Part 84).
While these marks have historically been protected under common law, they are now registered with the USPTO and are therefore subject to additional protections under the Lanham Act, 15 U.S.C. §§ 1051 *et seq*. In addition to being registered in the United States, N95 and NIOSH Approved are registered in several international jurisdictions. ***Any misuse of the aforementioned marks on products released to the market or associated with their packaging or marketing description, including (1) respirators that have failed to satisfy NIOSH’s regulatory requirements or have not received NIOSH approval, and (2) any other type of face-worn products falsely claiming to be approved by NIOSH, is a direct violation of applicable trademark law and may be subject to enforcement action.***
FRAUD AND FRAUDULENT STATEMENTS
If the NIOSH Respirator Approval Program determines, at any time, that an approval holder, applicant,1 a third party acting on behalf of the applicant, or any other entity has engaged in any of the following:
Making any materially false, fictitious, or fraudulent statement or representation, including any omission or concealment of substantive fact, in any application or application-related material or communication; or
Misrepresenting or misusing the NIOSH manufacturer code, respirator approval number, or NIOSH title or logo; or
Misrepresenting or misusing any NIOSH or Respirator Approval Program-associated certification marks,this information may be reported to the HHS Office of the General Counsel (OGC) and the Office of Inspector General (OIG). Any person who knowingly and willfully makes any false statement, misrepresentation, concealment of fact, or any other act of fraud to obtain any benefit from the NIOSH Respirator Approval Program may be *subject to civil and/or administrative remedies as well as felony criminal prosecution and may, under appropriate criminal provisions, be punished by a fine or imprisonment or both*pursuant to 18 U.S.C. § 1001*.*
Additionally, due to concerns over fraud and misrepresentation, NIOSH will not respond to emails that lack recognizable company domains. Examples include emails such as 3894876@hotnet.net, cv2009@vip.126.com, or 3273865@qq.com. NIOSH will only respond to inquiries about an approval application or request from an email address recognizably associated with a legitimate business or organization.NIOSH fraud and fraudulent statements policy and information about the NIOSH Respirator Approval Program certification marks. This notice supersedes NIOSH CA 2022-1041-R1. [PDF – 285 KB]P100 is a certification mark of the U.S. Department of Health and Human Services (HHS) registered in the United States.
N95 and NIOSH Approved are certification marks of the U.S. Department of Health and Human Services (HHS) registered in the United States and several international jurisdictions.
1 “Applicant” means an individual, partnership, company, corporation, association, or other organization that designs, manufactures, assembles, or controls the assembly of a respirator and who seeks to obtain a certificate of approval for such respirator. See 42 C.F.R. § 84.2.
							
					
							Last Reviewed:  April 25, 2023						Source: 	National Institute for Occupational Safety and Health
					Facebook
        Twitter
        LinkedIn
        Syndicate homeNPPTL
What’s New on the NPPTL Websiteplus icon
NPPTL What’s New Archives
A to Z Index
Respiratory Protection Videos
Resources for Mine Workers
Resources for Emergency Responders
Respirator Approval Programplus icon
Respirator Approval Information
Respirator Standards
Respirator User Notices
Resources and Technical Support
Post-market Evaluationsplus icon
PPE CASE Reports
PPE CASE Notes
Respirator Assessments to Support COVID-19 Responseplus icon
Beyond Shelf Life/Stockpiled Assessment Results
International Assessment Results
Decontaminated Assessment Results
Non-NIOSH Approved Innovative Filtering Facepiece Respirator Assessment Results
Protective Clothing and Ensembles
Personal Protective Technology Program
NIOSH Respiratory Protection Week 2023
NPPTL Infographics
NPPTL Fact Sheets
Healthcare Respiratory Protection Resourceplus icon
Policies and Procedures
Program Administrator
Evaluation and Selection
Medical Evaluation
Fit Testing
Proper Use and Storage
Training
Program Evaluation
Recordkeeping
Support for Firefighter Personal Protective Equipmentplus icon
Self-Contained Breathing Apparatusplus icon
Program Overview
Evaluation Process
Completed Reports
Resources
Firefighter Turnout Gearplus icon
Current Projects
Completed Projects
Participation on Standards Setting Organizations
Resources
Considerations for Selecting Protective Clothing
NPPTL Participation in Standard Development Committees
Respiratory Protection Information Trusted Sourceplus icon
Types of Respiratory Protection
Use of NIOSH-approved Respirators
Frequently Asked Questionsplus icon
Respirator FAQs
Fit Test FAQs
NIOSH Approval FAQs
Healthcare Setting Specific FAQs
Approved Particulate Filtering Facepiece Respirators
Certified Equipment List (CEL)
PPE CASE Reports
Respirator User Notices
Meetings, Webinars, & Conferencesplus icon
Archived Meetings and Conferences
Conformity Assessment Notices and Letters to Respirator Manufacturers and Interested Parties
About NPPTL
Contact NPPTL Connect with NPPTL Subscribe to Listserv
PPE concerns? Contact Us
 Follow NIOSH Facebook
Pinterest
Twitter
YouTube
 NIOSH Homepage NIOSH A-Z
Workplace Safety & Health Topics
Publications and Products
Programs
Contact NIOSH


About CDC
					Contact Us
					800-232-4636
 Facebook Twitter Instagram LinkedIn Youtube Pinterest Snapchat
 CONTACT CDC
				Contact Us
							Call 800-232-4636
							Email Us
			ABOUT CDC
				About CDC
							Jobs
							Funding
			POLICIES
				Accessibility
							External Links
							Privacy
							Policies
							No Fear Act
							FOIA
							OIG
							Nondiscrimination
							Vulnerability Disclosure Policy
			CONNECT WITH US
				Facebook
								Twitter
								Instagram
								LinkedIn
							Youtube
								Pinterest
								Snapchat
								Email
			LANGUAGES
				Español
							繁體中文
							Tiếng Việt
							한국어
							Tagalog
							Русский
							العربية
							Kreyòl Ayisyen
							Français
							Polski
							Português
							Italiano
							Deutsch
							日本語
							فارسی
							English


U.S. Department of Health & Human Services
			Accessibility
			External Links
			Privacy
			Policies
			No Fear Act
			FOIA
			Nondiscrimination
			OIG
			Vulnerability Disclosure Policy
			USA.gov


Exit Notification / Disclaimer Policy Close
 Links with this icon  indicate that you are leaving the CDC website. The Centers for Disease Control and Prevention (CDC) cannot attest to the accuracy of a non-federal website.
				Linking to a non-federal website does not constitute an endorsement by CDC or any of its employees of the sponsors or the information and products presented on the website.
				You will be subject to the destination website's privacy policy when you follow the link.
				CDC is not responsible for Section 508 compliance (accessibility) on other federal or private website. Website Disclaimers
 Cancel Continue